Curaleaf Holdings, Inc. (CURLF)

3.8550 -0.0450 (-1.15%) At close: 03:59PM EST

Curaleaf Holdings, Inc.

301 Edgewater Place
Suite 405
Wakefield, MA 01880
United States
781 451 0159
https://www.curaleaf.com

Sector(s): Healthcare
Industry: Drug Manufacturers—Specialty & Generic
Full-time employees: 5,600

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Boris Alexis Jordan	Exec. Chairman	1.75M	N/A	1966
Mr. Joseph F. Lusardi	Exec. Vice-Chairman	1.1M	12.75M	1974
Mr. Joseph Daniel Bayern	Exec. Officer & Exec. of New Markets	1.35M	N/A	1963
Mr. Matthew S. Darin	Chief Exec. Officer	N/A	N/A	N/A
Mr. Edward Kremer	Chief Financial Officer	N/A	N/A	1972
Mr. Joe Holland	Exec. VP of Operations	N/A	N/A	N/A
Mr. Camilo Russi Lyon	Chief Investment Officer	N/A	N/A	N/A
Mr. Jakob Feinstein	Mang. of Investor Relations	N/A	N/A	N/A
Mr. Peter Clateman J.D.	Chief Legal Officer	N/A	N/A	1968
Mr. James S. Shorris	Chief Compliance Officer	N/A	N/A	1962

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of September 20, 2022, it operated 137 dispensaries and 26 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.

Corporate governance

Curaleaf Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.